Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Traws Pharma (TRAW) Assets Average (2016 - 2025)

Traws Pharma's Assets Average history spans 13 years, with the latest figure at $11.5 million for Q4 2025.

  • Quarterly results put Assets Average at $11.5 million for Q4 2025, down 31.97% from a year ago — trailing twelve months through Dec 2025 was $11.5 million (down 31.97% YoY), and the annual figure for FY2025 was $17.8 million, down 25.32%.
  • Assets Average for Q4 2025 was $11.5 million at Traws Pharma, down from $14.0 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $57.7 million in Q4 2021 to a low of $11.5 million in Q4 2025.
  • The 5-year median for Assets Average is $30.8 million (2023), against an average of $32.0 million.
  • The sharpest move saw Assets Average surged 155.5% in 2021, then crashed 51.97% in 2024.
  • Year by year, Assets Average stood at $57.7 million in 2021, then dropped by 27.99% to $41.6 million in 2022, then tumbled by 40.2% to $24.9 million in 2023, then crashed by 31.82% to $16.9 million in 2024, then plummeted by 31.97% to $11.5 million in 2025.
  • According to Business Quant data, Assets Average over the past three periods came in at $11.5 million, $14.0 million, and $17.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.